The BRAF is proto-oncogene [72] and has been found to be mutated in a variety of cancers, including non-small cell lung cancer, colorectal cancer, and melanoma to mediate the oncogenetic phenotype [73–75]. This evidence concerns the gene BRAF and colorectal cancer.